Derivation of vaccines from mimotopes. Immunologic properties of human hepatitis B virus surface antigen mimotopes displayed on filamentous phage. [PDF]
Annalisa Meola+7 more
openalex +1 more source
Viral vector- and virus-like particle-based vaccines against infectious diseases: A minireview
To overcome the limitations of conventional vaccines, new platforms for vaccine design have emerged such as those based on viral vectors and virus-like particles (VLPs).
Ruth Henríquez, Isabel Muñoz-Barroso
doaj
A Quick and Simple Polarographic Method for Aluminum Measurement in Recombinant Hepatitis B Vaccine
Background and Objective: Aluminum salts are among the most common useful additive compounds in preparation of human and animal vaccines. Aluminum phosphate and aluminum hydroxide are two additives that show good immunoadjuvant effects with many antigens.
Mahmoud Alebouyeh+5 more
doaj
Twelve-year follow-up of a prospective randomized trial of hepatitis b recombinant DNA yeast vaccine versus plasma-derived vaccine without booster doses in children [PDF]
Man‐Fung Yuen+4 more
openalex +1 more source
Clinical and Economic Impact of a Combination Haemophilus influenzae and Hepatitis B Vaccine [PDF]
A. Mark Fendrick+3 more
openalex +1 more source
Immunogenicity of Two Doses of Yeast Recombinant Hepatitis B Vaccine in Healthy Older Adults [PDF]
Bruce G. Gellin+6 more
openalex +1 more source
The Nurse Practitioner's Immuniser Role in Primary Healthcare: A Scoping Review
ABSTRACT Aim(s) This scoping review aimed to explore and identify literature about the scope of practice for nurse practitioners working as immunisers in primary healthcare. Design The review was conducted according to the JBI scoping review framework.
Christine Schoenfisch+2 more
wiley +1 more source
Therapeutic options for human papillomavirus‐positive tonsil and base of tongue cancer
Abstract The incidences of human papillomavirus‐positive (HPV+) tonsillar and base tongue squamous cell carcinomas (TSCC and BOTSCC) have increased in recent decades. Notably, HPV+ TSCC and BOTSCC have a significantly better prognosis than their HPV‐negative counterparts when treated with current surgical options, radiotherapy, or intensified ...
Mark Zupancic+3 more
wiley +1 more source